Murphy Middleton Hinkle & Parker’s Cardinal Health CAH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $1.86M | Buy |
7,849
+1
| +0% | +$208 | 0.76% | 40 |
|
|
2026
Q1 | $1.66M | Buy |
+7,848
| New | +$1.69M | 0.77% | 38 |
|
|
2025
Q4 | – | Sell |
-7,848
| Closed | -$1.23M | – | 145 |
|
|
2025
Q3 | $1.23M | Buy |
7,848
+1
| +0% | +$154 | 0.6% | 51 |
|
|
2025
Q2 | $1.08M | Hold |
7,847
| – | – | 0.61% | 48 |
|
|
2025
Q1 | $1.08M | Hold |
7,847
| – | – | 0.61% | 48 |
|
|
2024
Q4 | $928K | Buy |
7,847
+1
| +0% | +$117 | 0.52% | 59 |
|
|
2024
Q3 | $867K | Buy |
7,846
+1
| +0% | +$105 | 0.47% | 65 |
|
|
2024
Q2 | $771K | Buy |
7,845
+1
| +0% | +$102 | 0.45% | 66 |
|
|
2024
Q1 | $878K | Hold |
7,844
| – | – | 0.51% | 63 |
|
|
2023
Q4 | $791K | Buy |
7,844
+1
| +0% | +$99 | 0.49% | 68 |
|
|
2023
Q3 | $681K | Buy |
7,843
+1
| +0% | +$90 | 0.44% | 71 |
|
|
2023
Q2 | $742K | Hold |
7,842
| – | – | 0.46% | 66 |
|
|
2023
Q1 | $592K | Buy |
7,842
+1
| +0% | +$75 | 0.37% | 80 |
|
|
2022
Q4 | $603K | Buy |
7,841
+1
| +0% | +$76 | 0.38% | 76 |
|
|
2022
Q3 | $523K | Buy |
7,840
+2
| +0% | +$127 | 0.36% | 86 |
|
|
2022
Q2 | $410K | Buy |
7,838
+1
| +0% | +$57 | 0.27% | 94 |
|
|
2022
Q1 | $444K | Buy |
7,837
+502
| +7% | +$26.9K | 0.24% | 99 |
|
|
2021
Q4 | $378K | Buy |
7,335
+2
| +0% | +$98 | 0.2% | 109 |
|
|
2021
Q3 | $363K | Buy |
7,333
+1
| +0% | +$54 | 0.21% | 107 |
|
|
2021
Q2 | $419K | Buy |
7,332
+2
| +0% | +$117 | 0.23% | 100 |
|
|
2021
Q1 | $445K | Buy |
7,330
+1
| +0% | +$55 | 0.26% | 97 |
|
|
2020
Q4 | $393K | Buy |
7,329
+1
| +0% | +$52 | 0.26% | 97 |
|
|
2020
Q3 | $344K | Sell |
7,328
-73
| -1% | -$3.75K | 0.25% | 96 |
|
|
2020
Q2 | $386K | Sell |
7,401
-269
| -4% | -$13.9K | 0.28% | 94 |
|
|
2020
Q1 | $368K | Buy |
7,670
+2
| +0% | +$104 | 0.33% | 87 |
|
|
2019
Q4 | $388K | Buy |
7,668
+1
| +0% | +$52 | 0.26% | 98 |
|
|
2019
Q3 | $362K | Sell |
7,667
-30
| -0.4% | -$1.37K | 0.26% | 93 |
|
|
2019
Q2 | $363K | Sell |
7,697
-87
| -1% | -$4.01K | 0.26% | 92 |
|
|
2019
Q1 | $375K | Buy |
7,784
+1
| +0% | +$50 | 0.26% | 94 |
|
|
2018
Q4 | $347K | Sell |
7,783
-824
| -10% | -$43K | 0.26% | 93 |
|
|
2018
Q3 | $465K | Buy |
8,607
+2
| +0% | +$102 | 0.33% | 80 |
|
|
2018
Q2 | $420K | Sell |
8,605
-207
| -2% | -$11.7K | 0.31% | 83 |
|
|
2018
Q1 | $552K | Sell |
8,812
-472
| -5% | -$32.4K | 0.43% | 69 |
|
|
2017
Q4 | $569K | Buy |
+9,284
| New | +$574K | 0.42% | 68 |
|
Other funds holding CAH
KC
ORIO
AIM
WCM
QCM
P
CAMG
Murphy Middleton Hinkle & Parker's CAH Position: Q2 2026 in Review
Murphy Middleton Hinkle & Parker increased its Cardinal Health (CAH) stake by 0.01% in Q2 2026, buying an estimated $208 and bringing the position to 7,849 shares worth $1.86M. The position accounts for 0.76% of the portfolio, ranked #40.
Murphy Middleton Hinkle & Parker first reported a position in CAH in Q4 2017 and has held it in 34 quarters since. 284 funds tracked by Wall St. Rank hold CAH as of Q2 2026.
- Murphy Middleton Hinkle & Parker held 7,849 shares of Cardinal Health worth $1.86M as of Q2 2026.
- Murphy Middleton Hinkle & Parker bought 1 Cardinal Health share in Q2 2026, an estimated $208.
- Cardinal Health made up 0.76% of Murphy Middleton Hinkle & Parker's portfolio in Q2 2026, its #40 holding.
- Murphy Middleton Hinkle & Parker first reported a position in Cardinal Health in Q4 2017 and has held it in 34 quarters since.
- 284 funds tracked by Wall St. Rank held Cardinal Health as of Q2 2026.
Based on Murphy Middleton Hinkle & Parker's 13F filing for Q2 2026, filed 14 Jul 2026.